Financials
- Market Capitalization 29.64 M
- Employee 29
- Founded 2017
- CEO N/A
- Website www.bioxceltherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00K20GVD2
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-0.28
Fiyat/satışlar oranı
25.81
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 4484 | KYNB Kyntra Bio, Inc. - Common Stock | 7.42 USD | +1.37% | -0.40% | +5.40% | -21.98% | 30.04 M USD | ||
| 4485 | TVRD Tvardi Therapeutics, Inc. - Common Stock | 3.18 USD | +2.58% | +1.27% | +20.91% | -11.67% | 29.83 M USD | ||
| 4489 | SER Serina Therapeutics, Inc. Common Stock | 1.97 USD | -7.94% | -7.94% | +7.07% | +18.32% | 29.55 M USD | ||
| 4499 | ATNM Actinium Pharmaceuticals, Inc. Common Stock | 0.91 USD | +1.11% | -9.00% | -10.78% | -12.50% | 28.55 M USD |